Cormorant Asset Management, LP - 30 Jun 2025 SCHEDULE 13G/A Report for VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share (VYNE)

Filing Manager: Cormorant Asset Management, LP
Reporting Manager: Cormorant Asset Management, LP
Security: VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol: VYNE
Shares outstanding: 16,657,813 shares
Disclosed Ownership: 1,370,938 shares
Ownership: 8.2%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 15:04:01 UTC
Date of event: 30 Jun 2025
Previous filing: 19 May 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cormorant Asset Management, LP	8.2%	1,370,938	0	1,370,938	/s/ Bihua Chen	Bihua Chen, Managing Member
Bihua Chen	8.2%	1,370,938	0	1,370,938	/s/ Bihua Chen	Bihua Chen